Display options
Share it on

J Affect Disord. 2020 Feb 15;263:310-317. doi: 10.1016/j.jad.2019.11.124. Epub 2019 Nov 30.

Purpose in life is a robust protective factor of reported cognitive decline among late middle-aged adults: The Emory Healthy Aging Study.

Journal of affective disorders

Aliza P Wingo, Thomas S Wingo, Wen Fan, Sharon Bergquist, Alvaro Alonso, Michele Marcus, Allan I Levey, James J Lah

Affiliations

  1. Division of Mental Health, Atlanta VA Medical Center, Decatur, GA, USA; Department of Psychiatry, Emory University School of Medicine, Atlanta, GA, USA. Electronic address: [email protected].
  2. Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA.
  3. Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
  4. Department of Epidemiology, Rollins School of Public Health, Emory University, GA, USA.

PMID: 31969260 PMCID: PMC6989389 DOI: 10.1016/j.jad.2019.11.124

Abstract

BACKGROUND: Cognitive abilities tend to decline in advanced age. A novel protective factor of cognitive decline in advanced age is purpose-in-life (PiL), a trait-like tendency to derive life meanings and purpose. However, whether PiL protects against cognitive decline in late-middle-age is unclear. Hence, we examined the association between PiL and perceived cognitive decline, one of the earliest detectable cognitive symptoms before the onset of cognitive impairment. Furthermore, we used a machine learning approach to investigate whether PiL is a robust predictor of cognitive decline when considered with the known protective and risk factors for cognition.

METHODS: PiL was assessed with a 10-item questionnaire and perceived cognitive decline with the Cognitive Function Instrument among 5,441 Emory Healthy Aging Study participants, whose mean age was 63 and 51% were employed. Association between PiL and perceived cognitive decline was examined with linear regression adjusting for relevant confounding factors. Elastic Net was performed to identify the most robust predictors of cognitive decline.

RESULTS: Greater PiL was associated with less perceived cognitive decline after adjusting for the relevant factors. Furthermore, Elastic Net modeling suggested that PiL is a robust predictor of cognitive decline when considered simultaneously with known protective (education, exercise, enrichment activities) and risk factors for cognition (depression, anxiety, diagnosed medical, mental health problems, smoking, alcohol use, family history of dementia, and others).

LIMITATION: This is a cross-sectional study.

CONCLUSIONS: PiL is a robust protective factor of perceived cognitive decline observed as early as middle age. Thus, interventions to enhance PiL merit further investigation.

Copyright © 2019. Published by Elsevier B.V.

Conflict of interest statement

Declaration of Competing Interest None

References

  1. Neurology. 2015 Sep 8;85(10):898-904 - PubMed
  2. Alzheimers Dement (Amst). 2015 May 02;1(2):194-205 - PubMed
  3. J Psychosom Res. 2013 May;74(5):427-32 - PubMed
  4. J Behav Med. 2013 Apr;36(2):124-33 - PubMed
  5. Health Qual Life Outcomes. 2006 Oct 04;4:76 - PubMed
  6. Isr J Psychiatry Relat Sci. 2015;52(3):68-70 - PubMed
  7. Annu Rev Clin Psychol. 2017 May 8;13:369-396 - PubMed
  8. J Affect Disord. 2009 Apr;114(1-3):163-73 - PubMed
  9. Arch Intern Med. 2006 May 22;166(10):1092-7 - PubMed
  10. Palliat Support Care. 2019 Feb;17(1):21-28 - PubMed
  11. Neurology. 2012 Sep 25;79(13):1332-9 - PubMed
  12. Ageing Res Rev. 2006 Aug;5(3):354-69 - PubMed
  13. J Stat Softw. 2010;33(1):1-22 - PubMed
  14. J Pers Soc Psychol. 1995 Oct;69(4):719-27 - PubMed
  15. J Aging Health. 2019 Sep;31(8):1398-1422 - PubMed
  16. Exp Aging Res. 2007 Jan-Mar;33(1):77-93 - PubMed
  17. J Am Geriatr Soc. 2005 Apr;53(4):616-21 - PubMed
  18. Soc Indic Res. 2010 Jul;97(3):357-373 - PubMed
  19. J Am Geriatr Soc. 2017 Dec;65(12):2627-2633 - PubMed
  20. Alzheimers Dement. 2017 Apr;13(4):406-418 - PubMed
  21. J Clin Oncol. 2012 Apr 20;30(12):1304-9 - PubMed
  22. J Subst Abuse Treat. 2011 Mar;40(2):183-8 - PubMed
  23. J Psychosom Res. 2016 Jun;85:1-8 - PubMed
  24. J Alzheimers Dis. 2017;60(2):427-437 - PubMed
  25. Br Med Bull. 2009;92:135-52 - PubMed
  26. Arch Gen Psychiatry. 2010 Mar;67(3):304-10 - PubMed
  27. J Affect Disord. 2010 May;122(3):213-7 - PubMed
  28. Am J Geriatr Psychiatry. 2010 Dec;18(12):1093-102 - PubMed
  29. Med Care. 2008 Mar;46(3):266-74 - PubMed
  30. Neurology. 2015 Nov 24;85(21):1852-8 - PubMed
  31. Psychol Addict Behav. 2015 Sep;29(3):716-24 - PubMed
  32. Br J Psychol. 1992 Feb;83 ( Pt 1):133-45 - PubMed
  33. J Affect Disord. 2019 Mar 1;246:731-737 - PubMed
  34. Lancet. 2016 Jul 30;388(10043):505-17 - PubMed
  35. JAMA Neurol. 2015 Apr;72(4):446-54 - PubMed
  36. Psychol Aging. 2002 Jun;17(2):179-93 - PubMed
  37. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2017 Nov;24(6):662-671 - PubMed
  38. Cancer. 2019 Jul 15;125(14):2383-2393 - PubMed
  39. Br J Psychiatry. 2018 Nov;213(5):654-660 - PubMed
  40. J Epidemiol Community Health. 2018 Aug;72(8):685-694 - PubMed
  41. Brain. 2018 Aug 1;141(8):2475-2485 - PubMed
  42. Brain. 2017 Mar 1;140(3):804-812 - PubMed
  43. Am J Public Health. 2010 Dec;100(12):2379-84 - PubMed
  44. Arch Gen Psychiatry. 2012 May;69(5):499-505 - PubMed
  45. Stroke. 2015 Apr;46(4):1071-6 - PubMed
  46. Am J Epidemiol. 2019 Apr 1;188(4):664-673 - PubMed
  47. J Clin Psychol. 1986 Jan;42(1):5-21 - PubMed
  48. Arch Gen Psychiatry. 2010 Apr;67(4):414-22 - PubMed
  49. Acta Psychiatr Scand. 2013 Jul;128(1):3-20 - PubMed

MeSH terms

Publication Types

Grant support